Good points made. Also, it is easy to undervalue that we own the...

Good points made. Also, it is easy to undervalue that we own the ‘crown jewels’ with the Atcor division having developed the only FDA cleared device for non-invasive measurement of central blood pressure monitoring plus over the years they have accumulated all the data sets from physiological and clinical trials using this technology, which of course is vital for proving equivalence to FDA for our conneqt products coming. (This and our patent portfolio creates a good moat for the competitors coming after us). I can’t wait to buy these conneqt products for my own use plus see what it is going to do to our share price!